Friday, July 31, 2026

Samsung Unveils Galaxy Watch 8 with Breakthrough Carotenoid and Heart Health Sensors

Samsung highlights sensor innovations in the Galaxy Watch 8 series, including carotenoid measurement and enhanced ECG monitoring.

Kim Jong Un’s Warning: No Tolerance for Loss of Life in Flood Crisis

North Korea, currently focused on recovering from flood damage, has emphasized the importance of minimizing the impact of natural disasters.

Kim Jong Un Prioritizes Military Over Economy in First Half of 2025, Report Shows

Kim Jong Un prioritizes military over civilian affairs, focusing on strengthening forces ahead of the Workers' Party's 80th anniversary.

Tag: Biotech

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Kolon Group’s Biotech Bet Faces Uncertainty as October Trial Readout Becomes Critical

Kolon TissueGene's TG-C osteoarthritis treatment failed its first U.S. Phase 3 trial, raising doubts about the biotech's future.

Celltrion Group’s 2 Trillion KRW Investment: What It Means for Global Bio Manufacturing by 2032

Celltrion Group plans a 2 trillion KRW investment to enhance production capacity and establish a leading position in global biotech.

Regenerative Medicine Expanded to Four Diseases Including Knee Osteoarthritis; Medipost and CHA Biotech Seen as Potential Beneficiaries

The Korean government is easing regulations on regenerative medicine, boosting biotech, and enabling patient access to validated therapies.

Hanmi Pharmaceutical completes acquisition of Aptose Biosciences

Hanmi Pharmaceutical has acquired Aptose Biosciences for $46.7 million, regaining rights to the cancer drug tuspetinib.

Galux: “Beyond Molecular Design, AI Will Run Entire Drug Discovery Process Within 10 Years”

Generative AI in drug discovery is evolving towards agentic AI, which will autonomously manage the entire process, says Galux CEO Seok Chaok.

K-Bio shifts focus to clinical data as key trial readouts stack up in second half

Korea's biotech sector shifts focus to clinical data in H2 2023, with key results from leading companies expected to drive investor sentiment.

SK Chemicals and J2H Biotech Partner for Breakthrough MASH Treatment: What You Need to Know

SK Chemicals partners with J2H Biotech to develop J2H-1702, a treatment for metabolic-associated steatotic liver disease, enhancing drug pipeline.

[Lillie report] Lilly’s Pacific-facing innovation hub brings K-biotech future to Songdo

Lilly Gateway Labs in San Diego supports early-stage biotechs, expanding to Korea with Samsung Biologics to foster innovation.

LegoChem expands options beyond early ADC licensing into late-stage clinical development

LegoChem Biosciences secures funding to advance ADC therapies into late-stage trials, enhancing strategic flexibility in biotech.

Big Pharma Turns to AI, China to Capital—What K-Bio Faced in San Diego [BIO USA Wrap-Up]

The BIO International Convention 2026 highlighted AI's role in biotech, emphasizing supply chain shifts and the need for capital investment.

From Keycaps to World Cup Matches, K-Bio Turns BIO USA Into a Marketing Showcase

The BIO International Convention 2026 showcased innovative marketing and cultural engagement, enhancing the biotech industry's global appeal.

Is BTGEN the Next Big Player in Biopharmaceuticals? Discover Their Unique CDMO Strategy

BTGEN is expanding its CDMO business with National Growth Fund support, focusing on innovative processes instead of competing on scale.

K-Beauty Shines at BIO USA 2026: Discover the Future of Bio-Integrated Skincare!

K-Beauty showcased its biotech innovations at BIO USA 2026 with a pop-up store, attracting global attention and business opportunities.

Supply Chains, M&A and AI: As China Closes In, K-Bio Faces a Critical Window of Opportunity [BIO USA]

Korea's biotech industry faces challenges and opportunities amid global restructuring, emphasizing AI and support for startups at BIO USA 2026.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.